Amgen continues with Tour of California
Pharmaceutical company to support 2012 race
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
You are now subscribed
Your newsletter sign-up was successful
The Tour of California will continue under the banner of pharmaceutical giant Amgen for the seventh consecutive year. AEG vice president Kristin Bachochin confirmed the news to Cyclingnews today.
"We are happy and pleased to confirm that Amgen will remain as the title sponsor of the 2012 race," Bachochin said.
Amgen has partnered with the race since its inception, using the race to promote its cancer advocacy initiatives. In conjunction with the race and non-profit partners, Amgen launched the Breakaway from Cancer to promote awareness of resources for cancer patients.
The Amgen Tour of California will begin in Santa Rosa in 2012.
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!

Laura Weislo is a Cyclingnews veteran of 20 years. Having joined in 2006, Laura extensively covered the Operacion Puerto doping scandal, the years-long conflict between the UCI and the Tour de France organisers ASO over the creation of the WorldTour, and the downfall of Lance Armstrong and his lifetime ban for doping. As Managing Editor, Laura coordinates coverage for North American events and global news.
